Authorized Generics: Effect on Pharmaceutical Market
Journal Title: International Journal of Novel Trends in Pharmaceutical Sciences - Year 2012, Vol 2, Issue 1
Abstract
The study addresses the effect of authorized generics practice in pharmaceutical market. The practice of marketing an “authorized generic” has been growing in the pharmaceutical industry. An “authorized generic”–sometimes termed a “branded,” or “pseudo” generic–is a pharmaceutical that is marketed by or on behalf of a brand name drug company, but is sold under a generic name. The brand drug companies employ a generic company or its own generic subsidiary to market their drug product; under their own new drug application (NDA). Authorized Generics compete on price, quality and availability basis with generic products approved by the FDA as substitutable for specific brand products. Over the past couple of years, innovator drug companies have been launching authorized generics simultaneously with the first Abbreviated New Drug Applications (ANDA) filer’s launch of its generic drug product. The study analyzed the current prospects of authorized generics practice, examines the effect of authorized generics practice on consumers affordability to medicines, effects on the generic companies to file paragraph IV certifications to challenge patented drugs, study also observed the effect of authorized generics practice on Indian pharma companies. The questionnaire were prepared relevant to study and distributed to the Indian pharma regulatory personnel, and their responses were analyzed.
Authors and Affiliations
M Mangesh , Chitrivekar , Lokesh Chitrivekar, D Shreedhar, N Udupa, Rupesh Ramteke
Keywords
Related Articles
- EP ID EP93423
- DOI -
- Views 98
- Downloads 0
Identification of Molecular sequence relationships between Culex quinquefasciatus and Aedes aegypti using Bioinformatics techniques
When two symbolic representations of DNA or protein sequences are arranged next to one another so that their most similar elements are juxtaposed they are said to be aligned. Many bioinformatics tasks depend upon success...
Design and Evaluation of Sustained Release Bilayer Tablet of Metformin Hydrochloride with Metoprolol Tartrate
Diabetes mellitus generally accompanied with major complications like Hypertension, Cardio myopathy, Stroke, Hyperlipidemia, Ischemic cerebrovascular disease, and Peripheral vascular disease. These conditions accou...
Protein modelling, identification of de novo chemical inhibitor and QSAR studies on PCOS (Polycystic Ovary Syndrome) using cheminformatics software and tools
In this Insilico research project, Polycystic Ovary syndrome analysis was carried out. Protein modeling and drug designing were major steps for delivering the best drug candidates for disease target. The identified prote...
Drug designing and toxicity prediction studies on Atherosclerosis gene (CETP) using Insilico software and tools
More than 15,800,000 Americans have been affected by coronary artery disease. About 8 million of them have had heart attacks. Around 500,000 people will die of coronary artery disease this year. More than a million will...
Insilco Homology Modeling of Contactin 5 Protein which is Responsible for Diabetic retinopathy
Diabetic retinopathy, the most common diabetic eye disease, occurs when blood vessels in the retina change. Sometimes these vessels swell and leak fluid or even close off completely. In other cases, abnormal new blood ve...